- January 2021 |
- Healthcare & Pharmaceutical / Pharmaceuticals
Global Saxagliptin Sales Market, By Dosage(2.5 mg, 5 mg, Others), By Distribution Channel(Hospital Pharmacy, Retail Pharmacy, Others), By Region (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America); Trend Analysis, Competitive Market Share & Forecast, 2020-2026
Global Saxagliptin Sales Market Size – Industry Trends & Forecast Report 2026
The Global Saxagliptin Sales Market has reached USD in 2019 and is further projected to reach USD by 2026, rising at a CAGR of throughout the forecast period. The market for saxagliptin is motivating by the increasing cases of diabetes worldwide. North America and Europe are important markets for saxagliptin worldwide. This is attributed to a large number of an aging population and the increasing prevalence of type II diabetes. Factors such as increasing healthcare expenses, a large pool of patients, and rising government funding are attributing to the market development of saxagliptin in the Asia Pacific.
Source: BlueWeave Consulting
Global Saxagliptin Sales Market Overview:
Saxagliptin is the drug used to cure diabetes. It works by increasing the level of insulin in the body produced after the meal. The product is advertised under the brand name called Onglyza. Saxagliptin acts on a normal hormone in the body, which is called incretins. The product has many side effects such as headache, upper respiratory tract infection, urinary tract infection, and nasopharyngitis. Saxagliptin can also cause problems like stroke and heart attack.
Global Saxagliptin Sales Market
Rising Incidences of Type II Diabetes to Aid the Global Market Growth of Saxagliptin
The market for saxagliptin is being determined by the growing incidences of type II diabetes across the globe. The market drivers, such as improved sedentary lifestyle, growing prevalence of increased government funding, obesity, and junk food conducts, are subsidizing the market growth of saxagliptin. Further, rising healthcare awareness is expected to fuel market development over the forecast period. The market is expanding due to further inventions taking place in the saxagliptin industry. This is further expected to aid market growth over the prediction period. However, the market is expected to witness a setback due to the reasons, such as stringent regulations for the approval of drugs and the availability of alternatives for the conduct of diabetes.
Increase in Sedentary Lifestyle
The increase in demand of various products increased with the rise in the type II diabetes cases...